Key result
Thrombolytic therapy in elderly patients (>70 years) with acute STEMI was associated with an in-hospital mortality rate of 30.2% and an intracranial hemorrhage rate of 0.9%.
Why the study?
Many large, randomized trials have excluded patients over 70 years old, leaving the benefits and complications of thrombolytic therapy in elderly patients with STEMI unclear.
What are the in-hospital outcomes and complication rates of thrombolytic therapy in elderly patients (>70 years) with acute STEMI?
Observational (n=106)
No
What are the in-hospital outcomes and complication rates of thrombolytic therapy in elderly patients (>70 years) with acute STEMI?
Thrombolytic therapy in elderly STEMI patients (>70 years) is associated with a high in-hospital mortality (30.2%) and complication rate, though it remains a necessary option when primary PCI is not feasible.
Answers are grounded in this paper and cite their sources.
High associated mortality warrants caution with thrombolysis in elderly STEMI when PCI unavailable; leaves open need for randomized comparisons.
Objective: Ischemic heart disease is the leading cause of mortality in population above the age of 70 years. ST-elevation myocardial infarction (STEMI) constitutes important treatable cause of death in elderly population. However, many large, randomized trials have excluded this age group. The present study was planned to find out the benefits and complications related to thrombolytic therapy in elderly patients. Materials and Methods: The study was done between January 1, 2019, and December 31, 2019, in the Department of Cardiology, Sri Jayadeva Institute Of Cardiovascular Sciences and Research, Bengaluru, India, which included the study group comprising 106 elderly patients (age >70 years) with acute STEMI and underwent thrombolytic therapy. All patients were followed up till the index hospitalization and evaluated for in-hospital outcome. Results: Out of the 106 patients in the study group, 64 (60.38%) were male and 42 (39.62%) were female. Out of which, 88 (83%) patients were between 70 and 80 years whereas 18 (17%) patients were >80 years. Mortality was happened in 32 patients (30.2%). Coronary angiogram post thrombolysis was performed as pharmacoinvasive or rescue percutaneous coronary intervention (PCI) in 25 patients (23.6%), and cardiac arrhythmias were noted in 22 (20.6%) patients, acute kidney injury in 7 (6.6%) patients, ventricular septal rupture in 5.7%, ischemic stroke in 4.7%, free-wall rupture in 2.8%, and intracranial hemorrhage in 0.9% of patients. Conclusions: Primary PCI may offer clinical advantage over fibrinolytic therapy as manifested by the trends toward improvements in the combined endpoint of death, reinfarction, and stroke in the oldest patients. Despite the higher prevalence of comorbidities and high-risk features in elderly patients of acute STEMI, timely thrombolysis is also beneficial particularly who present early after symptom onset, absence of comorbid condition, and lower NYHA class on admission (NYHA I/II). In developing countries like India where primary PCI may not be feasible, timely thrombolysis should be given to the elderly patients also.
No takes yet. Share an insight, caveat, or question.
Thakkar et al. (2022) conducted an observational in ST-elevation myocardial infarction (STEMI) (n=106). Thrombolytic therapy was evaluated on In-hospital mortality. Thrombolytic therapy in elderly patients (>70 years) with acute STEMI was associated with an in-hospital mortality rate of 30.2% and an intracranial hemorrhage rate of 0.9%.
Synapse has enriched 10 related papers. Consider them for comparative context: